| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 43 | 2024 | 515 | 12.100 |
Why?
|
| Renal Insufficiency, Chronic | 38 | 2023 | 302 | 9.250 |
Why?
|
| Living Donors | 31 | 2024 | 64 | 8.790 |
Why?
|
| Kidney Failure, Chronic | 37 | 2022 | 548 | 7.160 |
Why?
|
| Renal Dialysis | 32 | 2023 | 282 | 5.320 |
Why?
|
| Kidney Diseases | 19 | 2022 | 249 | 5.110 |
Why?
|
| Healthcare Disparities | 20 | 2022 | 183 | 4.070 |
Why?
|
| Hypertension | 28 | 2023 | 1024 | 4.010 |
Why?
|
| Patient Education as Topic | 16 | 2019 | 261 | 3.860 |
Why?
|
| Humans | 195 | 2024 | 34562 | 3.480 |
Why?
|
| Kidney | 18 | 2023 | 528 | 3.410 |
Why?
|
| Attitude to Health | 15 | 2020 | 161 | 3.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 16 | 2018 | 364 | 3.010 |
Why?
|
| United States | 71 | 2023 | 4278 | 2.730 |
Why?
|
| Health Services Accessibility | 11 | 2022 | 260 | 2.720 |
Why?
|
| Tissue and Organ Procurement | 10 | 2022 | 99 | 2.590 |
Why?
|
| Primary Health Care | 12 | 2022 | 240 | 2.500 |
Why?
|
| Family | 10 | 2022 | 123 | 2.270 |
Why?
|
| Nephrology | 9 | 2021 | 33 | 2.120 |
Why?
|
| Middle Aged | 85 | 2023 | 12726 | 2.030 |
Why?
|
| Diabetes Mellitus | 8 | 2023 | 439 | 2.000 |
Why?
|
| Renal Replacement Therapy | 7 | 2021 | 18 | 1.980 |
Why?
|
| Adult | 70 | 2023 | 10030 | 1.910 |
Why?
|
| Female | 98 | 2023 | 21531 | 1.890 |
Why?
|
| Socioeconomic Factors | 17 | 2023 | 446 | 1.880 |
Why?
|
| Residence Characteristics | 5 | 2023 | 188 | 1.790 |
Why?
|
| Decision Making | 10 | 2018 | 203 | 1.770 |
Why?
|
| Cross-Sectional Studies | 28 | 2023 | 1607 | 1.760 |
Why?
|
| Male | 93 | 2023 | 20739 | 1.730 |
Why?
|
| Self Care | 6 | 2023 | 144 | 1.700 |
Why?
|
| Delivery of Health Care | 6 | 2022 | 176 | 1.700 |
Why?
|
| Kidney Function Tests | 6 | 2023 | 107 | 1.680 |
Why?
|
| Patient Participation | 6 | 2021 | 93 | 1.610 |
Why?
|
| Aged | 59 | 2022 | 11022 | 1.470 |
Why?
|
| Glomerular Filtration Rate | 19 | 2021 | 315 | 1.430 |
Why?
|
| Tissue Donors | 8 | 2022 | 208 | 1.370 |
Why?
|
| Communication | 7 | 2021 | 144 | 1.310 |
Why?
|
| Trust | 3 | 2020 | 45 | 1.130 |
Why?
|
| Patient-Centered Care | 4 | 2018 | 77 | 1.130 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2022 | 177 | 1.120 |
Why?
|
| Telemedicine | 4 | 2019 | 120 | 1.120 |
Why?
|
| Medication Adherence | 2 | 2020 | 163 | 1.070 |
Why?
|
| Asthma | 2 | 2020 | 274 | 1.030 |
Why?
|
| Referral and Consultation | 7 | 2022 | 149 | 1.020 |
Why?
|
| Social Work | 4 | 2015 | 8 | 0.970 |
Why?
|
| Cooperative Behavior | 4 | 2019 | 87 | 0.930 |
Why?
|
| Awards and Prizes | 2 | 2022 | 13 | 0.920 |
Why?
|
| Antihypertensive Agents | 6 | 2021 | 379 | 0.920 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 168 | 0.890 |
Why?
|
| Renal Insufficiency | 3 | 2020 | 58 | 0.880 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 136 | 0.850 |
Why?
|
| Biomedical Research | 6 | 2021 | 186 | 0.830 |
Why?
|
| Physician-Patient Relations | 5 | 2018 | 188 | 0.820 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2021 | 48 | 0.820 |
Why?
|
| Registries | 8 | 2023 | 328 | 0.810 |
Why?
|
| Liver Transplantation | 3 | 2023 | 186 | 0.800 |
Why?
|
| Blood Pressure | 10 | 2023 | 901 | 0.790 |
Why?
|
| Young Adult | 20 | 2021 | 2831 | 0.790 |
Why?
|
| Interdisciplinary Communication | 3 | 2015 | 60 | 0.790 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2023 | 5 | 0.780 |
Why?
|
| Risk Factors | 30 | 2021 | 4137 | 0.780 |
Why?
|
| Cardiovascular Diseases | 12 | 2023 | 1209 | 0.760 |
Why?
|
| Information Dissemination | 3 | 2021 | 56 | 0.760 |
Why?
|
| Disease Progression | 10 | 2022 | 634 | 0.760 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2022 | 11 | 0.740 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 326 | 0.740 |
Why?
|
| Informed Consent | 2 | 2012 | 45 | 0.710 |
Why?
|
| American Medical Association | 1 | 2021 | 5 | 0.700 |
Why?
|
| Editorial Policies | 1 | 2021 | 14 | 0.700 |
Why?
|
| Health Status Disparities | 7 | 2022 | 138 | 0.690 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 4157 | 0.680 |
Why?
|
| Financial Support | 2 | 2018 | 5 | 0.680 |
Why?
|
| Environmental Health | 1 | 2020 | 9 | 0.670 |
Why?
|
| Catheters, Indwelling | 1 | 2021 | 44 | 0.660 |
Why?
|
| Coronavirus | 1 | 2020 | 2 | 0.660 |
Why?
|
| Quality Indicators, Health Care | 3 | 2020 | 64 | 0.650 |
Why?
|
| Patient Selection | 2 | 2022 | 291 | 0.650 |
Why?
|
| Treatment Outcome | 19 | 2023 | 3623 | 0.640 |
Why?
|
| Health Behavior | 2 | 2019 | 246 | 0.640 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 91 | 0.640 |
Why?
|
| Prevalence | 10 | 2023 | 1034 | 0.640 |
Why?
|
| Public Health | 3 | 2019 | 94 | 0.630 |
Why?
|
| Chronic Disease | 9 | 2023 | 439 | 0.610 |
Why?
|
| Guideline Adherence | 3 | 2014 | 122 | 0.610 |
Why?
|
| Continuity of Patient Care | 2 | 2020 | 75 | 0.610 |
Why?
|
| Vulnerable Populations | 2 | 2019 | 40 | 0.590 |
Why?
|
| Research Design | 4 | 2015 | 337 | 0.580 |
Why?
|
| Attitude of Health Personnel | 4 | 2015 | 193 | 0.580 |
Why?
|
| Iron | 3 | 2017 | 121 | 0.580 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.580 |
Why?
|
| Dialysis | 1 | 2018 | 3 | 0.580 |
Why?
|
| Fluorocarbon Polymers | 1 | 2018 | 2 | 0.580 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 103 | 0.580 |
Why?
|
| Quality of Health Care | 2 | 2015 | 159 | 0.570 |
Why?
|
| Baltimore | 8 | 2019 | 50 | 0.570 |
Why?
|
| Comparative Effectiveness Research | 3 | 2013 | 30 | 0.570 |
Why?
|
| Adolescent | 14 | 2021 | 3805 | 0.570 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 22 | 0.570 |
Why?
|
| Mass Screening | 5 | 2011 | 269 | 0.560 |
Why?
|
| Energy Intake | 1 | 2019 | 138 | 0.560 |
Why?
|
| Patient Transfer | 1 | 2018 | 43 | 0.550 |
Why?
|
| Cultural Competency | 3 | 2014 | 18 | 0.540 |
Why?
|
| Environmental Exposure | 1 | 2018 | 91 | 0.540 |
Why?
|
| Risk Assessment | 13 | 2021 | 1508 | 0.530 |
Why?
|
| Health Services Research | 2 | 2012 | 82 | 0.530 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 123 | 0.530 |
Why?
|
| Patient Preference | 1 | 2018 | 49 | 0.530 |
Why?
|
| Diet | 2 | 2022 | 418 | 0.520 |
Why?
|
| Social Support | 4 | 2019 | 195 | 0.500 |
Why?
|
| Absenteeism | 1 | 2016 | 10 | 0.490 |
Why?
|
| Efficiency | 1 | 2016 | 18 | 0.490 |
Why?
|
| Patient Discharge | 2 | 2020 | 214 | 0.480 |
Why?
|
| Physical Examination | 2 | 2007 | 94 | 0.480 |
Why?
|
| Prospective Studies | 15 | 2022 | 2463 | 0.470 |
Why?
|
| Internship and Residency | 1 | 2020 | 330 | 0.470 |
Why?
|
| Waiting Lists | 6 | 2022 | 36 | 0.470 |
Why?
|
| Evidence-Based Medicine | 4 | 2012 | 230 | 0.470 |
Why?
|
| Health Promotion | 3 | 2013 | 264 | 0.470 |
Why?
|
| Patient Care Team | 3 | 2018 | 130 | 0.470 |
Why?
|
| Coronary Disease | 4 | 2020 | 239 | 0.470 |
Why?
|
| Longitudinal Studies | 8 | 2023 | 802 | 0.460 |
Why?
|
| Minority Groups | 3 | 2016 | 90 | 0.460 |
Why?
|
| Preventive Health Services | 4 | 2015 | 39 | 0.460 |
Why?
|
| Health Services Needs and Demand | 2 | 2014 | 84 | 0.460 |
Why?
|
| Problem Solving | 3 | 2023 | 29 | 0.450 |
Why?
|
| Income | 7 | 2020 | 68 | 0.450 |
Why?
|
| Creatinine | 3 | 2015 | 206 | 0.450 |
Why?
|
| Health Care Costs | 1 | 2016 | 126 | 0.450 |
Why?
|
| Depression | 4 | 2023 | 458 | 0.430 |
Why?
|
| Clinical Competence | 2 | 2017 | 349 | 0.430 |
Why?
|
| Peritoneal Dialysis | 2 | 2013 | 25 | 0.410 |
Why?
|
| Family Relations | 2 | 2019 | 24 | 0.410 |
Why?
|
| Patient Satisfaction | 5 | 2018 | 245 | 0.400 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 41 | 0.400 |
Why?
|
| Time Factors | 15 | 2020 | 2353 | 0.380 |
Why?
|
| Retrospective Studies | 9 | 2023 | 3825 | 0.380 |
Why?
|
| Incidence | 10 | 2020 | 1290 | 0.380 |
Why?
|
| Needs Assessment | 1 | 2013 | 81 | 0.370 |
Why?
|
| Blood Donors | 2 | 2002 | 13 | 0.370 |
Why?
|
| Comorbidity | 10 | 2020 | 596 | 0.360 |
Why?
|
| Research | 1 | 2012 | 88 | 0.360 |
Why?
|
| Public Opinion | 1 | 2012 | 17 | 0.360 |
Why?
|
| Cohort Studies | 8 | 2023 | 1910 | 0.360 |
Why?
|
| Prejudice | 4 | 2009 | 51 | 0.360 |
Why?
|
| Research Support as Topic | 2 | 2022 | 36 | 0.350 |
Why?
|
| Proteinuria | 4 | 2009 | 55 | 0.350 |
Why?
|
| Organ Transplantation | 2 | 2022 | 67 | 0.350 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 26 | 0.350 |
Why?
|
| Hospitalization | 8 | 2022 | 500 | 0.350 |
Why?
|
| Cultural Diversity | 2 | 2021 | 21 | 0.340 |
Why?
|
| Intention | 1 | 2011 | 31 | 0.340 |
Why?
|
| Veterans | 3 | 2016 | 73 | 0.340 |
Why?
|
| Prognosis | 8 | 2022 | 1606 | 0.340 |
Why?
|
| Vitamin D | 3 | 2023 | 187 | 0.330 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 267 | 0.330 |
Why?
|
| Quality of Life | 5 | 2021 | 1032 | 0.330 |
Why?
|
| Follow-Up Studies | 8 | 2014 | 2367 | 0.320 |
Why?
|
| Social Justice | 4 | 2021 | 19 | 0.320 |
Why?
|
| Cadaver | 3 | 2006 | 170 | 0.320 |
Why?
|
| Albuminuria | 4 | 2014 | 181 | 0.300 |
Why?
|
| Self Concept | 1 | 2009 | 47 | 0.300 |
Why?
|
| Social Class | 3 | 2020 | 94 | 0.290 |
Why?
|
| Logistic Models | 5 | 2019 | 808 | 0.280 |
Why?
|
| Odds Ratio | 3 | 2022 | 480 | 0.270 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 33 | 0.260 |
Why?
|
| Stroke | 4 | 2020 | 700 | 0.260 |
Why?
|
| Resource Allocation | 1 | 2007 | 9 | 0.260 |
Why?
|
| Health Status | 3 | 2022 | 411 | 0.260 |
Why?
|
| Nutritional Status | 2 | 2019 | 80 | 0.250 |
Why?
|
| Qualitative Research | 4 | 2019 | 199 | 0.250 |
Why?
|
| Maryland | 6 | 2014 | 28 | 0.240 |
Why?
|
| Motivation | 4 | 2014 | 123 | 0.230 |
Why?
|
| Urinalysis | 2 | 2011 | 27 | 0.230 |
Why?
|
| Anemia | 2 | 2017 | 58 | 0.220 |
Why?
|
| Nephrectomy | 2 | 2006 | 127 | 0.220 |
Why?
|
| Anatomy | 1 | 2004 | 4 | 0.220 |
Why?
|
| Risk-Taking | 1 | 2005 | 97 | 0.220 |
Why?
|
| Insurance, Health | 4 | 2010 | 98 | 0.220 |
Why?
|
| Atherosclerosis | 2 | 2020 | 837 | 0.210 |
Why?
|
| Brain Ischemia | 2 | 2016 | 160 | 0.210 |
Why?
|
| Focus Groups | 3 | 2014 | 125 | 0.210 |
Why?
|
| Systems Analysis | 1 | 2023 | 3 | 0.210 |
Why?
|
| Hospitals | 3 | 2016 | 105 | 0.210 |
Why?
|
| Databases, Factual | 4 | 2020 | 380 | 0.200 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2023 | 3 | 0.200 |
Why?
|
| Educational Status | 4 | 2020 | 185 | 0.200 |
Why?
|
| Communication Barriers | 2 | 2015 | 21 | 0.200 |
Why?
|
| Religion | 4 | 2021 | 31 | 0.200 |
Why?
|
| Bayes Theorem | 1 | 2023 | 85 | 0.200 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2012 | 565 | 0.200 |
Why?
|
| Graft Survival | 3 | 2021 | 315 | 0.200 |
Why?
|
| Radiopharmaceuticals | 1 | 2023 | 103 | 0.200 |
Why?
|
| Violence | 1 | 2023 | 18 | 0.190 |
Why?
|
| Obesity | 2 | 2022 | 1246 | 0.190 |
Why?
|
| Statistical Distributions | 1 | 2002 | 5 | 0.190 |
Why?
|
| Health Policy | 1 | 2023 | 96 | 0.190 |
Why?
|
| Professional-Family Relations | 2 | 2012 | 17 | 0.180 |
Why?
|
| Child | 4 | 2020 | 2614 | 0.180 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2002 | 37 | 0.180 |
Why?
|
| Ambulatory Care Facilities | 2 | 2020 | 87 | 0.180 |
Why?
|
| Poverty | 3 | 2019 | 118 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1523 | 0.170 |
Why?
|
| Behavior Therapy | 1 | 2002 | 107 | 0.170 |
Why?
|
| Pilot Projects | 3 | 2012 | 585 | 0.170 |
Why?
|
| North Carolina | 3 | 2021 | 1613 | 0.170 |
Why?
|
| Research Personnel | 1 | 2021 | 24 | 0.170 |
Why?
|
| Friends | 1 | 2021 | 8 | 0.170 |
Why?
|
| Data Collection | 4 | 2013 | 191 | 0.170 |
Why?
|
| Eligibility Determination | 1 | 2021 | 18 | 0.170 |
Why?
|
| Cities | 1 | 2020 | 8 | 0.170 |
Why?
|
| Models, Statistical | 1 | 2022 | 193 | 0.170 |
Why?
|
| Counseling | 2 | 2019 | 99 | 0.170 |
Why?
|
| Hypoglycemia | 1 | 2021 | 45 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2020 | 28 | 0.160 |
Why?
|
| Urban Population | 2 | 2019 | 97 | 0.160 |
Why?
|
| Health Care Rationing | 2 | 2012 | 12 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 59 | 0.160 |
Why?
|
| Peer Group | 2 | 2019 | 45 | 0.160 |
Why?
|
| Allostasis | 1 | 2020 | 12 | 0.160 |
Why?
|
| Sleep | 1 | 2020 | 90 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2020 | 50 | 0.150 |
Why?
|
| Ownership | 1 | 2019 | 15 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2020 | 43 | 0.150 |
Why?
|
| Internal Medicine | 1 | 2020 | 57 | 0.150 |
Why?
|
| Resuscitation | 1 | 2020 | 69 | 0.150 |
Why?
|
| Mississippi | 4 | 2020 | 38 | 0.150 |
Why?
|
| Potassium, Dietary | 1 | 2019 | 5 | 0.150 |
Why?
|
| Community-Based Participatory Research | 3 | 2016 | 122 | 0.150 |
Why?
|
| Phosphorus, Dietary | 1 | 2019 | 3 | 0.150 |
Why?
|
| Dietary Fiber | 1 | 2019 | 20 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2019 | 15 | 0.150 |
Why?
|
| Perception | 3 | 2014 | 107 | 0.150 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 21 | 0.150 |
Why?
|
| Psychology | 1 | 2019 | 25 | 0.150 |
Why?
|
| Magnesium | 1 | 2019 | 30 | 0.150 |
Why?
|
| Patient Advocacy | 1 | 2018 | 12 | 0.140 |
Why?
|
| Survival Rate | 4 | 2014 | 928 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 168 | 0.140 |
Why?
|
| Blood Pressure Determination | 2 | 2014 | 108 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 56 | 0.140 |
Why?
|
| Commerce | 1 | 2019 | 70 | 0.140 |
Why?
|
| Reminder Systems | 1 | 2018 | 23 | 0.140 |
Why?
|
| Health Personnel | 1 | 2020 | 131 | 0.140 |
Why?
|
| Interviews as Topic | 2 | 2019 | 272 | 0.140 |
Why?
|
| Societies, Medical | 2 | 2009 | 168 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2018 | 79 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 325 | 0.140 |
Why?
|
| Health Care Surveys | 3 | 2014 | 191 | 0.130 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 39 | 0.130 |
Why?
|
| Physicians | 2 | 2014 | 169 | 0.130 |
Why?
|
| Documentation | 1 | 2017 | 44 | 0.130 |
Why?
|
| Attitude | 2 | 2011 | 43 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2009 | 113 | 0.130 |
Why?
|
| Trace Elements | 1 | 2017 | 7 | 0.130 |
Why?
|
| Age Factors | 4 | 2021 | 1262 | 0.130 |
Why?
|
| Videoconferencing | 1 | 2017 | 7 | 0.130 |
Why?
|
| Self-Help Groups | 1 | 2017 | 11 | 0.130 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 804 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2017 | 55 | 0.120 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 16 | 0.120 |
Why?
|
| Government Programs | 1 | 2016 | 11 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2002 | 850 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 305 | 0.120 |
Why?
|
| Public Policy | 1 | 2016 | 34 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2019 | 323 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2018 | 954 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 431 | 0.120 |
Why?
|
| Donor Selection | 1 | 2015 | 36 | 0.110 |
Why?
|
| Electronic Health Records | 2 | 2015 | 184 | 0.110 |
Why?
|
| Food Supply | 1 | 2015 | 68 | 0.110 |
Why?
|
| Iron Compounds | 1 | 2014 | 2 | 0.110 |
Why?
|
| Models, Organizational | 1 | 2015 | 19 | 0.110 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2014 | 5 | 0.110 |
Why?
|
| Nurses | 1 | 2014 | 14 | 0.110 |
Why?
|
| Troponin I | 1 | 2014 | 25 | 0.110 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 89 | 0.100 |
Why?
|
| Random Allocation | 2 | 2006 | 257 | 0.100 |
Why?
|
| Prescriptions | 1 | 2013 | 15 | 0.100 |
Why?
|
| Systole | 1 | 2014 | 103 | 0.100 |
Why?
|
| Disease Management | 2 | 2017 | 134 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2014 | 168 | 0.100 |
Why?
|
| Medical Informatics | 1 | 2013 | 27 | 0.100 |
Why?
|
| Heart Failure | 2 | 2011 | 780 | 0.100 |
Why?
|
| Pamphlets | 1 | 2012 | 5 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 10 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 102 | 0.090 |
Why?
|
| Age Distribution | 2 | 2021 | 211 | 0.090 |
Why?
|
| Acetaminophen | 1 | 2012 | 20 | 0.090 |
Why?
|
| Video Recording | 1 | 2012 | 64 | 0.090 |
Why?
|
| African Americans | 1 | 2019 | 1435 | 0.090 |
Why?
|
| Fever | 1 | 2012 | 63 | 0.090 |
Why?
|
| Sterols | 2 | 2023 | 3 | 0.090 |
Why?
|
| Sex Factors | 3 | 2007 | 707 | 0.090 |
Why?
|
| Goals | 1 | 2012 | 36 | 0.090 |
Why?
|
| Inpatients | 1 | 2012 | 88 | 0.090 |
Why?
|
| Parathyroid Hormone | 2 | 2023 | 47 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2012 | 88 | 0.090 |
Why?
|
| Employment | 2 | 2002 | 52 | 0.090 |
Why?
|
| Cause of Death | 3 | 2020 | 245 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 510 | 0.090 |
Why?
|
| Health Education | 1 | 2012 | 170 | 0.090 |
Why?
|
| Disclosure | 1 | 2011 | 33 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 430 | 0.090 |
Why?
|
| Clinical Protocols | 1 | 2011 | 87 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 590 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2002 | 508 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 849 | 0.080 |
Why?
|
| Physician's Role | 1 | 2011 | 41 | 0.080 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 138 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 62 | 0.080 |
Why?
|
| Civil Rights | 1 | 2009 | 7 | 0.080 |
Why?
|
| Adaptation, Psychological | 2 | 2021 | 145 | 0.070 |
Why?
|
| Awareness | 1 | 2008 | 28 | 0.070 |
Why?
|
| Patients | 1 | 2008 | 48 | 0.070 |
Why?
|
| Medicare | 1 | 2009 | 224 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2009 | 248 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 274 | 0.070 |
Why?
|
| Medicaid | 2 | 2023 | 105 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2007 | 197 | 0.060 |
Why?
|
| Genotype | 2 | 2019 | 744 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2009 | 703 | 0.060 |
Why?
|
| Telephone | 1 | 2006 | 67 | 0.060 |
Why?
|
| Canada | 1 | 2006 | 69 | 0.060 |
Why?
|
| Surgical Instruments | 1 | 2006 | 25 | 0.060 |
Why?
|
| Linear Models | 2 | 2009 | 465 | 0.060 |
Why?
|
| Altruism | 1 | 2005 | 6 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2021 | 194 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2017 | 67 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2006 | 109 | 0.060 |
Why?
|
| Length of Stay | 2 | 2007 | 335 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 542 | 0.050 |
Why?
|
| Health Priorities | 2 | 2014 | 18 | 0.050 |
Why?
|
| Diffusion of Innovation | 2 | 2014 | 35 | 0.050 |
Why?
|
| Causality | 2 | 2013 | 38 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2003 | 35 | 0.050 |
Why?
|
| Markov Chains | 1 | 2003 | 32 | 0.050 |
Why?
|
| Naphthalenes | 1 | 2023 | 53 | 0.050 |
Why?
|
| Vitamins | 1 | 2023 | 75 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 926 | 0.050 |
Why?
|
| Probability | 1 | 2003 | 168 | 0.050 |
Why?
|
| Marriage | 1 | 2002 | 6 | 0.050 |
Why?
|
| Occupations | 1 | 2002 | 10 | 0.050 |
Why?
|
| Fear | 1 | 2002 | 46 | 0.050 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 73 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 51 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2002 | 82 | 0.040 |
Why?
|
| Social Environment | 1 | 2021 | 82 | 0.040 |
Why?
|
| Hypotension, Orthostatic | 1 | 2021 | 15 | 0.040 |
Why?
|
| Medical Assistance | 1 | 2021 | 3 | 0.040 |
Why?
|
| Computer Security | 1 | 2021 | 9 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 16 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 2001 | 2 | 0.040 |
Why?
|
| Review Literature as Topic | 1 | 2001 | 8 | 0.040 |
Why?
|
| Government Regulation | 1 | 2021 | 32 | 0.040 |
Why?
|
| Actigraphy | 1 | 2020 | 15 | 0.040 |
Why?
|
| Minerals | 1 | 2020 | 15 | 0.040 |
Why?
|
| Polysomnography | 1 | 2020 | 41 | 0.040 |
Why?
|
| Phosphates | 1 | 2020 | 28 | 0.040 |
Why?
|
| Propensity Score | 1 | 2020 | 51 | 0.040 |
Why?
|
| Diabetes Complications | 2 | 2014 | 189 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 152 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 369 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 318 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2012 | 155 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 200 | 0.040 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2019 | 9 | 0.040 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 61 | 0.040 |
Why?
|
| History, 20th Century | 2 | 2009 | 76 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 129 | 0.040 |
Why?
|
| Insulin | 1 | 2021 | 394 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2020 | 207 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2019 | 254 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2018 | 94 | 0.030 |
Why?
|
| Financing, Organized | 1 | 2017 | 17 | 0.030 |
Why?
|
| Emotions | 1 | 2018 | 60 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 53 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 310 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 49 | 0.030 |
Why?
|
| Indians, North American | 1 | 2016 | 110 | 0.030 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 18 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2016 | 44 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 515 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2018 | 233 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 52 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2015 | 22 | 0.030 |
Why?
|
| Kenya | 1 | 2015 | 21 | 0.030 |
Why?
|
| Consumer Health Information | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2015 | 128 | 0.030 |
Why?
|
| Food Preferences | 1 | 2014 | 36 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 33 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 156 | 0.030 |
Why?
|
| Ferritins | 1 | 2014 | 51 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2014 | 12 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 561 | 0.030 |
Why?
|
| Career Choice | 1 | 2014 | 45 | 0.030 |
Why?
|
| Community Health Services | 1 | 2014 | 50 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 35 | 0.030 |
Why?
|
| Health Literacy | 1 | 2014 | 31 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2014 | 111 | 0.030 |
Why?
|
| Institutionalization | 1 | 2013 | 2 | 0.030 |
Why?
|
| Education, Medical | 1 | 2014 | 73 | 0.030 |
Why?
|
| Uremia | 1 | 2013 | 9 | 0.030 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hyperkalemia | 1 | 2013 | 16 | 0.030 |
Why?
|
| Systems Integration | 1 | 2013 | 11 | 0.030 |
Why?
|
| Nursing Homes | 1 | 2013 | 33 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 24 | 0.020 |
Why?
|
| Massachusetts | 1 | 2012 | 29 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 16 | 0.020 |
Why?
|
| Mortality | 1 | 2013 | 127 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2013 | 146 | 0.020 |
Why?
|
| Animals | 2 | 2014 | 8578 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 823 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 755 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 614 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 12 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2009 | 15 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 182 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2007 | 62 | 0.020 |
Why?
|
| Marital Status | 1 | 2007 | 22 | 0.020 |
Why?
|
| Hemostasis, Surgical | 1 | 2006 | 12 | 0.010 |
Why?
|
| Korea | 1 | 2005 | 3 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 205 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 273 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2003 | 28 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 529 | 0.010 |
Why?
|
| Societies, Scientific | 1 | 2001 | 16 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2001 | 57 | 0.010 |
Why?
|